• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性活动性肝炎和肝硬化患者肝血流与凝血指标之间的相关性

Correlation between hepatic blood flow and coagulation indices in chronic active hepatitis and liver cirrhosis patients.

作者信息

Violi F, Alessandri C, Saliola M, Caputo V, Bonavita M S, Balsano F

出版信息

Haemostasis. 1985;15(3):210-4. doi: 10.1159/000215146.

DOI:10.1159/000215146
PMID:4029756
Abstract

Hepatic blood flow (HBF) has been reported to reflect liver cell mass. HBF was studied in 21 patients with chronic active hepatitis (CAH) and in 20 patients with liver cirrhosis (LC). It was correlated with such indices of liver protein synthesis as serum albumin, Normotest, plasma activity of antithrombin III, prekallikrein, alpha 2-antiplasmin and plasminogen. No correlation between HBF and the examined parameters was seen in CAH. HBF correlated with all the indices of liver protein synthesis in LC, thus suggesting that serum albumin, antithrombin III, Normotest, prekallikrein, plasminogen, and alpha 2-antiplasmin could reflect the residual liver cell mass in LC.

摘要

据报道,肝血流量(HBF)可反映肝细胞量。对21例慢性活动性肝炎(CAH)患者和20例肝硬化(LC)患者的肝血流量进行了研究。将其与肝脏蛋白质合成指标如血清白蛋白、诺莫测试、抗凝血酶III、前激肽释放酶、α2-抗纤溶酶和纤溶酶原的血浆活性进行关联分析。在慢性活动性肝炎患者中未发现肝血流量与所检测参数之间存在相关性。在肝硬化患者中,肝血流量与肝脏蛋白质合成的所有指标均相关,这表明血清白蛋白、抗凝血酶III、诺莫测试、前激肽释放酶、纤溶酶原和α2-抗纤溶酶可反映肝硬化患者残余的肝细胞量。

相似文献

1
Correlation between hepatic blood flow and coagulation indices in chronic active hepatitis and liver cirrhosis patients.慢性活动性肝炎和肝硬化患者肝血流与凝血指标之间的相关性
Haemostasis. 1985;15(3):210-4. doi: 10.1159/000215146.
2
Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.前激肽释放酶在慢性活动性肝炎和肝硬化患者中的表现。
Haemostasis. 1984;14(2):218-22. doi: 10.1159/000215059.
3
Prekallikrein and factor VII as prognostic indexes of liver failure.
Am J Clin Pathol. 1986 May;85(5):579-82. doi: 10.1093/ajcp/85.5.579.
4
Hepatic hemodynamics in patients with chronic hepatitis or cirrhosis as assessed by organ-reflectance spectrophotometry.通过器官反射分光光度法评估慢性肝炎或肝硬化患者的肝脏血流动力学。
Gastroenterology. 1983 Mar;84(3):611-6.
5
Hepatic detoxification and hepatic function in chronic active hepatitis with and without cirrhosis.
Dig Dis Sci. 1988 Jan;33(1):41-6. doi: 10.1007/BF01536629.
6
[Evaluation of antipyrine clearance in chronic liver diseases].
Zhonghua Nei Ke Za Zhi. 1989 May;28(5):295-7, 315-6.
7
[The role of interleukin-6 and nitric oxide in pathogenesis of portal hypertension and decompensation of liver cirrhosis].
Klin Med (Mosk). 2012;90(1):47-9.
8
[Various parameters of hemostasis in patients with chronic liver diseases].[慢性肝病患者止血的各项参数]
Minerva Med. 1985 Aug 25;76(32-33):1469-72.
9
Relationship between hepatic blood flow, liver tests, haemodynamic values and clinical characteristics in patients with chronic liver disease.
J Gastroenterol Hepatol. 1997 Feb;12(2):167-71. doi: 10.1111/j.1440-1746.1997.tb00401.x.
10
[Measurement of regional hepatic blood flow with 133Xe per-rectal portal scintigraphy].[用¹³³Xe经直肠门静脉闪烁显像术测量肝脏局部血流]
Kaku Igaku. 1989 Oct;26(10):1279-84.

引用本文的文献

1
Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.慢性肝病中的Hageman因子、高分子量激肽原和前激肽释放酶
J Clin Pathol. 1986 Sep;39(9):1003-5. doi: 10.1136/jcp.39.9.1003.